(C6H8N3)+I3-和[(Cu3I4)(C8H17N2)]配体原位合成与结构表征

在溶剂热条件下, 以原位反应为基础合成了两个碘化物(C6H8N3)+I3-(1, C6H8N3=2,3-dihydroimi-dazo1,2-a]pyrimidin-1-ium, 2,3-二氢咪唑1,2-α]-嘧啶鎓阳离子)和(Cu3I4)(C8H17N2)](2, C8H17N2=N-ethyl-4-aza-1-azonia-bicyclo2.2.2]octane, N-乙基三乙烯二铵阳离子). 用元素分析、粉末X射线衍射及单晶X射线衍射等对化合物进行了表征. 结果表明, 化合物1属于三斜晶系, P1空间群, a=0.74281(15) nm, b=0.84241(17) nm, c=0.9993(2) nm, α=82.02(3)°, β=83.30(3)°, γ=82.92(3)°, V=0.6114(2) nm3. 化合物2属于单斜晶系, P21/c空间群, a=0.68924(14) nm, b=1.0786(2) nm, c=2.2779(5) nm, β=94.84(3)°, V=1.6874(6) nm3. 在两个化合物合成中存在两种不同类型的配体原位合成反应, 即化合物1的2-氨基嘧啶和乙醇的成环反应与化合物2的三乙烯二胺和乙醇的烷基化反应.

Synthesis and Structure Characterization of(C_6H_8N_3)~+I_3~- and [(Cu_3I_4)(C_8H_(17)N_2)] Based on in situ Ligand Reaction

Two I-containing compounds, (C6H8N3)+I3-(1, C6H7N3=2,3-dihydroimidazo1,2-a]pyrimidine-1-ium) and (Cu3I4)(C8H17N2)](2, C8H17N2=N-ethyl-1,4-diazabicyclo2.2.2]octane), were synthesized under solvothermal conditions based on in situ ligand reaction and characterized via elemental analysis, XRD and single crystal X-ray diffraction analysis. Complex 1 crystallizes in the triclinic system, space group P1 with a=0.74281(15) nm, b=0.84241(17) nm, c=0.9993(2) nm, α=82.02(3)°, β=83.30(3)°, γ=82.92(3)°, V=0.6114(2) nm3. Complex 2 crystallizes in the monoclinic system, space group P21/c with a=0.68924(14) nm, b=1.0786(2) nm, c=2.2779(5) nm, β=94.84(3)°, V=1.6874(6) nm3. Two kinds of in situ ligand reaction were found in the synthesis of these complexes. (C6H8N3)+ ligand was synthesized from 2-aminopyrimidine and ethanol in complex 1, whereas(C8H17N2)+ ligand was synthesized from 1,4-diazabicyclo2.2.2]octane and ethanol in complex 2.